Brian Mendel

Company: Ajinomoto Bio-Pharma Services

Job title: Director

Seminars:

Development of a Novel Chemical Site-Specific ADC Conjugation Platform with Enhanced Therapeutic Window 9:00 am

• Evaluating site-specific technologies that are being employed in many of the next generation ADCs due to enhanced biological properties in pre-clinical studies • Reporting a new method of affinity peptide mediated regiodivergent antibody functionalization that enables the synthesis of ADCs from native IgGs in a tunable and atom-precise mannerRead more

day: Day Two